Dr. Craig Koniver

For sure. And CoQ10 has been studied very safe, up to 2,400 milligrams a day, no harmful effects. Sometimes I'll take more, like I was telling you earlier, it's been dramatic for me with migraine headaches and basically reducing them to zero.

But it makes sense if you think about it, right? So if you took an antibiotic, right, like we can just an antibiotics can be very specific what it gets approved for in terms of like working against a specific bacteria. But then through clinical use and just experience, you know, we learned that, oh,

But it makes sense if you think about it, right? So if you took an antibiotic, right, like we can just an antibiotics can be very specific what it gets approved for in terms of like working against a specific bacteria. But then through clinical use and just experience, you know, we learned that, oh,

But it makes sense if you think about it, right? So if you took an antibiotic, right, like we can just an antibiotics can be very specific what it gets approved for in terms of like working against a specific bacteria. But then through clinical use and just experience, you know, we learned that, oh,

I can use doxycycline or a Z-Pak, azithromycin or whatever it is for a variety of bacterial infections that extend well beyond just what it's approved for. Well, that makes sense.

I can use doxycycline or a Z-Pak, azithromycin or whatever it is for a variety of bacterial infections that extend well beyond just what it's approved for. Well, that makes sense.

I can use doxycycline or a Z-Pak, azithromycin or whatever it is for a variety of bacterial infections that extend well beyond just what it's approved for. Well, that makes sense.

Exactly what happened with semiglutidinazempic, right? Approved for helping glucose utilization or lowering, you know, blood glucose in patients with type 2 diabetes. And they found through use only people were losing weight. Mm-hmm. And now it's become blockbuster. And we see it with, you know, things like, you know, repurposing drugs for cancer, right?

Exactly what happened with semiglutidinazempic, right? Approved for helping glucose utilization or lowering, you know, blood glucose in patients with type 2 diabetes. And they found through use only people were losing weight. Mm-hmm. And now it's become blockbuster. And we see it with, you know, things like, you know, repurposing drugs for cancer, right?

Exactly what happened with semiglutidinazempic, right? Approved for helping glucose utilization or lowering, you know, blood glucose in patients with type 2 diabetes. And they found through use only people were losing weight. Mm-hmm. And now it's become blockbuster. And we see it with, you know, things like, you know, repurposing drugs for cancer, right?

There's a lot of that going on, a lot of the repurposing. So, you know, doxycycline is a very common one that's used in cancer therapies, I think by sophisticated oncologists. I don't treat cancer, but by sophisticated oncologists to use things like doxycycline, metformin, mabendazole, which is an anti-parasitic drug, right, to help with cancer. That's amazing.

There's a lot of that going on, a lot of the repurposing. So, you know, doxycycline is a very common one that's used in cancer therapies, I think by sophisticated oncologists. I don't treat cancer, but by sophisticated oncologists to use things like doxycycline, metformin, mabendazole, which is an anti-parasitic drug, right, to help with cancer. That's amazing.

There's a lot of that going on, a lot of the repurposing. So, you know, doxycycline is a very common one that's used in cancer therapies, I think by sophisticated oncologists. I don't treat cancer, but by sophisticated oncologists to use things like doxycycline, metformin, mabendazole, which is an anti-parasitic drug, right, to help with cancer. That's amazing.

That's what happened with Ozempic. I mean, it's again, I write prescriptions. I think there's a time and place. I think it's challenging for me, though, right? And I think for a lot of physicians, it's become challenging operating in a paradigm

That's what happened with Ozempic. I mean, it's again, I write prescriptions. I think there's a time and place. I think it's challenging for me, though, right? And I think for a lot of physicians, it's become challenging operating in a paradigm

That's what happened with Ozempic. I mean, it's again, I write prescriptions. I think there's a time and place. I think it's challenging for me, though, right? And I think for a lot of physicians, it's become challenging operating in a paradigm

When we talk about chronic disease, which is essentially failing, I mean, and we all know this statistically, we're not making huge dents in heart disease, cancer, autoimmune disease, neurodegenerative. We're not at all, but we're spending exorbitant amounts of money. Right. And this is, you know, something that I had to learn over time.

When we talk about chronic disease, which is essentially failing, I mean, and we all know this statistically, we're not making huge dents in heart disease, cancer, autoimmune disease, neurodegenerative. We're not at all, but we're spending exorbitant amounts of money. Right. And this is, you know, something that I had to learn over time.

When we talk about chronic disease, which is essentially failing, I mean, and we all know this statistically, we're not making huge dents in heart disease, cancer, autoimmune disease, neurodegenerative. We're not at all, but we're spending exorbitant amounts of money. Right. And this is, you know, something that I had to learn over time.

And I don't know how I got into it, but when I started my practice. Back in 2006, I started, it was traditional family medicine practice, but I started using these nutritional IVs. And this is before hangover IVs, this is before it was popular. This is, you know, 20 years ago. And what I learned was that these nutritional IVs help people feel better quickly.